Houlihan Lokey (HLI)
NYSEFinancialsInvestment - Banking & Investment ServicesSnapshot 2026-09-04
$137.11+0.18%
Close 2026-09-04 · 1-day change
NYSEFinancialsInvestment - Banking & Investment ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · HLI
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $137 HLI trades at 20× p/e, below its 21× p/e peer median, but our blended $121 fair value sits below the price. We hold it with medium confidence: our number sits below the analyst range and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $145–$187. Note: our $121 fair value sits below the entire analyst range ($145–$187). Even valued only for durable growth at sustainable margins, it's worth about $172 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $161.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $279.86 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $290.88 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $30.33 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$145.00 – $187.00 (median $162.50) · 6 analysts · as of 2026-08-03
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Around its own typical valuation.
Trailing four: 2026-Q1, 2026-Q2, 2026-Q3, 2027-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $71.23 |
| — |
| — |
| TTM |
| high |
| Peer P/B | 12M | $73.07 | 2.2 | 33.36 | TTM | high |
| Peer P/FCF | 12M | $109.91 | 15.3 | 7.17 | TTM | high |
| Peer P/E | 12M | $140.53 | 20.8 | 6.76 | TTM | high |
| Peer P/S | 12M | $99.60 | 2.7 | 37.33 | TTM | high |
| PEG | 12M | $233.90 | 34.6 | 6.76 | TTM | high |
| residual income | 12M | $47.73 | — | — | TTM | high |
| Own P/E history | 12M | $126.04 | 18.6 | 6.76 | TTM | high |
| triangulated | 12M | $144.17 | 20.8 | 6.94 | Triangulated | high |
| Peer P/B | 3Y | $102.02 | 2.2 | 46.58 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $167.16 | 15.3 | 10.90 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $221.23 | 20.8 | 10.64 | Analyst | medium |
| Peer P/S | 3Y | $151.01 | 2.7 | 56.60 | Analyst | medium |
| PEG | 3Y | $368.22 | 34.6 | 10.64 | Analyst | medium |
| Own P/E history | 3Y | $198.42 | 18.6 | 10.64 | Analyst | medium |
| Peer P/B | 5Y | $127.44 | 2.2 | 58.18 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $221.07 | 15.3 | 14.42 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $290.05 | 20.8 | 13.95 | Analyst | high |
| Peer P/S | 5Y | $197.99 | 2.7 | 74.20 | Analyst | high |
| PEG | 5Y | $482.77 | 34.6 | 13.95 | Analyst | high |
| Own P/E history | 5Y | $260.15 | 18.6 | 13.95 | Analyst | high |